Fundraising Fox
Merida Biosciences
Founded 2022 · 64 employees on LinkedIn · 5 known investors
Find your way into Merida Biosciences
Sign up to see every warm intro you have to Merida Biosciences
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Merida Biosciences team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Merida is a biotherapeutics company developing a new class of drugs designed to selectively and durably eliminate the pathogenic antibodies that drive autoimmune and allergic diseases. Its work spans discovery, drug development, and clinical operations aimed at treating patients with these conditions.
Founders & leadership
Merida Biosciences was founded in 2022 by Pierre Bruhns and Mark Shlomchik.
Investors · 5
How we know: the company's own site · Bain Capital Life Sciences's portfolio page · funding news · Not right? Tell us
How we know: Third Rock Ventures's portfolio page · the company's own site · a partner's Signal profile · funding news · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: GV (Google Ventures)'s portfolio page · a partner's Signal profile · funding news · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: funding news · Not right? Tell us
Funding
SEC filings, press & company announcementsSource: company announcements and press reports — follow each round's link for the claim.
Founder mafia
2 people who came through Merida Biosciences went on to found or lead other companies.
In the news
Frequently asked questions
- What does Merida Biosciences do?
- Merida is a biotherapeutics company developing a new class of drugs designed to selectively and durably eliminate the pathogenic antibodies that drive autoimmune and allergic diseases. Its work spans discovery, drug development, and clinical operations aimed at treating patients with these conditions.
- Who founded Merida Biosciences?
- Merida Biosciences was founded by Pierre Bruhns, Mark Shlomchik in 2022.
- Who are Merida Biosciences's investors?
- Merida Biosciences's investors include Bain Capital Life Sciences, Third Rock Ventures, GV (Google Ventures), Biotechnology Value Fund, The Engine Ventures.